Recombinant human granulocyte-macrophage colony stimulating factor gel

A technology of colony-stimulating factor and macrophages, which can be applied in drug combinations, peptide/protein components, skin diseases, etc., can solve the problems of inconvenient use, and achieve convenient portability and use, stable and controllable quality, and clear mechanism of action Effect

Inactive Publication Date: 2003-08-13
HARBIN PHARMA GROUP TECH CENT
0 Cites 6 Cited by

AI-Extracted Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is aimed at the inconvenient technical problems and deficiencies in the use of freeze-dried dosage-type medical external-use biological products, and researches and develops a ...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Method used

The ulcer wound, burn wound, scald wound model that this gel and stoste, normal saline, matrix make after healthy guinea pig, healthy rabbit's health both sides depilate, group at random, carry out drug application comparat...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Abstract

A gel of recombinant human granulocyte-macrophage colony stimulating factor for treating ulcer, scald, burn, mucitis and mucosa wound is prepared from carbomer, propanetriol, sodium hydroxide, raw liquid, human plasma albumin, purified water, etc. Its advantages are high curative effect and low dosage.

Application Domain

Technology Topic

Human serum albuminGranulocyte macrophage colony-stimulating factor +10

Examples

  • Experimental program(1)

Example Embodiment

[0006] An example is given below. Choose 350 grams of glycerol, 15 grams of carbomer, 10 grams of benzzet, 5 grams of sodium hydroxide, 10 grams of human albumin, and 10 undiluted solution 6 International unit, the rest uses purified water, a total of 1000 grams, the weight ratio of each component is: glycerol 35%, carbomer 1.5%, benzine 1%, sodium hydroxide 0.5%, human albumin 1%, Purified water is added to 100%. Among the ingredients of the formula, glycerol is used as a matrix, stabilizer, and protective agent; carbomer is used as a drug carrier; benzalze is used as a transdermal absorption enhancer; sodium hydroxide is used as a neutralizer to shape the gel and adjust the pH of the gel at the same time (PH), which keeps the original solution biologically active; human albumin acts as a stabilizer and protective agent. The biological product is manufactured under normal temperature conditions. The product process is as follows: Put 15 grams of carbomer in an emulsification tank, add 350 grams of glycerol, mix, stir, and disperse, and wait until the carbomer is dispersed in glycerol. After homogenization, add 10 grams of benzzet's purified aqueous solution, mix and stir. Carbomer absorbs water and swells. After the matrix is ​​evenly mixed, add 5 grams of purified aqueous solution of sodium hydroxide, mix and stir again, and the matrix gradually thickens to become Uniform, smooth, and delicate hydrogel matrix, milky white and translucent; finally add stock solution 10 6 A purified aqueous solution of international units and 10 grams of human albumin, reaching a total weight of 1000 grams, lightly mix and stir to form a recombinant human granulocyte macrophage colony stimulating factor gel with uniform texture, smoothness and good spreadability. The gel is mainly used for wound diseases such as skin and mucous membrane ulcers, scalds, burns, etc., and is directly applied to the affected parts.
[0007] Models of ulcer wound, burn wound and scald wound made after depilation on both sides of the body of healthy guinea pigs and healthy rabbits with the original solution, physiological saline, and matrix were randomly divided into groups, and the applicator comparison test was carried out on three and seven days. After inspection, the three kinds of wound reduction degree and the treatment effect of the animal group using this gel were significantly better than the original solution, normal saline and matrix group.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Similar technology patents

Vinyl sulfonamide or vinyl amide compound and preparation method and application thereof

InactiveCN112010789AThe mechanism of action is clearNovel targetOrganic active ingredientsNervous disorderVinyl sulfonamideSulfonilamide
Owner:SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI

Traditional Chinese medicine composition for treating alzheimer disease, as well as preparation method and application thereof

InactiveCN104547388ASatisfied with the curative effectThe mechanism of action is clearNervous disorderDispersion deliveryHerbBlood circulation
Owner:HEILONGJIANG RUTAI BIOLOGICAL PHARMA

Pharmaceutical composition for treating depression, its preparation method and application

InactiveCN1840043AThe mechanism of action is clearGood curative effectNervous disorderSolution deliveryPolygalaAngelica archangelica
Owner:XUANWU HOSPITAL OF CAPITAL UNIV OF MEDICAL SCI

Mudstone ecological slope protection system and slope protection method

PendingCN112030875APracticalThe mechanism of action is clearClimate change adaptationCoastlines protectionBankClay soil
Owner:浙江广川工程咨询有限公司

Classification and recommendation of technical efficacy words

  • Lower dose
  • The mechanism of action is clear

Composite miticide for farmland and fruit trees

InactiveCN102484990AExcellent control effectLower doseBiocideAnimal repellantsAvermectinFruit tree
Owner:LIANBAO CROP TECH

Method for controlling crack of super-long wall body

InactiveCN101608476AThe mechanism of action is clearConcise construction proceduresWallsBuilding material handlingSteel platesWall plate
Owner:NINGBO CONSTR +2

Coastal glehnia root extract with function of antagonizing gastric ulcer and its prepn

InactiveCN101066286AThe mechanism of action is clearSimple preparation processSugar derivativesDigestive systemGlycoside formationChronic gastritis
Owner:SHENYANG PHARMA UNIVERSITY

Pharmaceutical composition for treating depression, its preparation method and application

InactiveCN1840043AThe mechanism of action is clearGood curative effectNervous disorderSolution deliveryPolygalaAngelica archangelica
Owner:XUANWU HOSPITAL OF CAPITAL UNIV OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products